SCHEMBL8154261

SCHEMBL8154261

O=C1c2ccc(-c3ccccc3)cc2CCN1CCN1CCC1

nearest known ligand 0.95

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 19/20 0.95
GRM5 P41594 1/20 0.69
KCNH2 Q12809 3/20 0.68
HTR1A P08908 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3646548 0.97 HRH3 (1.00) HRH3KCNH2HTR1A
SCHEMBL8162038 0.90 HRH3 (0.82) HRH3GRM5KCNH2HTR1A
SCHEMBL10242676 0.87 HRH3 (0.77) HRH3KCNH2HTR1A
SCHEMBL3655295 0.86 HRH3 (1.00) HRH3KCNH2HTR1A
SCHEMBL8227682 0.86 HRH3 (0.79) HRH3KCNH2
SCHEMBL3655913 0.85 HRH3 (1.00) HRH3KCNH2
SCHEMBL3650555 0.85 HRH3 (0.81) HRH3KCNH2HTR1A
SCHEMBL3650534 0.85 HRH3 (1.00) HRH3KCNH2HTR1A
SCHEMBL3655115 0.85 HRH3 (1.00) HRH3KCNH2HTR1A
Hydrochloric Acid SCHEMBL4534014 0.85 HRH3 (0.98) HRH3KCNH2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120028955-A1 BICYCLIC MGLUR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME VANDERBILT UNIVERSITY 2012-02-02 US disclosed
US-20120028956-A1 BICYCLIC MGLUR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME VANDERBILT UNIVERSITY 2012-02-02 US disclosed
US-8034806-B2 Bicyclic mGluR5 positive allosteric modulators and methods of making and using same VANDERBILT UNIVERSITY (US) 2011-10-11 US disclosed
US-20090270362-A1 BICYCLIC MGLUR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME VANDERBILT UNIVERSITY 2009-10-29 US disclosed
WO-2008151184-A1 BENZAMIDE MGLUR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME VANDERBILT UNIVERSITY (US) 2008-12-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120028955-A1 BICYCLIC MGLUR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME GRM5, GRIK5, GRM1 HRH3 838/4885GRM5 1/4885KCNH2 903/4885
US-20120028956-A1 BICYCLIC MGLUR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME GRM5, GRIK5, GRM1 HRH3 838/4885GRM5 1/4885KCNH2 903/4885
US-20090270362-A1 BICYCLIC MGLUR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME GRM5, GRIK5, GRM1 HRH3 838/4885GRM5 1/4885KCNH2 903/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.